Rheumatoid Arthritis (RA) associated interstitial lung disease (ILD).
AuthorsO'Dwyer, David N
Armstrong, Michelle E
Dodd, Jonathan D
Veale, Douglas J
Donnelly, Seamas C
AffiliationSchool of Medicine and Medical Science, College of Life Sciences, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland; National Pulmonary Fibrosis Referral Centre at St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
Local subject classificationRHEUMATOID ARTHRITIS
INTERSTITIAL LUNG DISEASE
Lung Diseases, Interstitial
MetadataShow full item record
CitationO'Dwyer, DN et al. Rheumatoid Arthritis (RA) associated interstitial lung disease (ILD). Eur. J. Intern. Med. 2013, 24 (7):597-603
JournalEuropean journal of internal medicine
AbstractRheumatoid Arthritis (RA) is the most common Connective Tissue Disease (CTD) and represents an increasing burden on global health resources. Interstitial lung disease (ILD) has been recognised as a complication of RA but its potential for mortality and morbidity has arguably been under appreciated for decades. New studies have underscored a significant lifetime risk of ILD development in RA. Contemporary work has identified an increased risk of mortality associated with the Usual Interstitial Pneumonia (UIP) pattern which shares similarity with the most devastating of the interstitial pulmonary diseases, namely Idiopathic Pulmonary Fibrosis (IPF). In this paper, we discuss recent studies highlighting the associated increase in mortality in RA-UIP. We explore associations between radiological and histopathological features of RA-ILD and the prognostic implications of same. We emphasise the need for translational research in this area given the growing burden of RA-ILD. We highlight the importance of the respiratory physician as a key stakeholder in the multidisciplinary management of this disorder. RA-ILD focused research offers the opportunity to identify early asymptomatic disease and define the natural history of this extra articular manifestation. This may provide a unique opportunity to define key regulatory fibrotic events driving progressive disease. We also discuss some of the more challenging and novel aspects of therapy for RA-ILD.
- Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
- Authors: Solomon JJ, Ryu JH, Tazelaar HD, Myers JL, Tuder R, Cool CD, Curran-Everett D, Fischer A, Swigris JJ, Brown KK
- Issue date: 2013 Aug
- [Interstitial lung disease in rheumatoid arthritis].
- Authors: Froidevaux-Janin S, Dudler J, Nicod LP, Lazor R
- Issue date: 2011 Nov 23
- Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
- Authors: de Lauretis A, Veeraraghavan S, Renzoni E
- Issue date: 2011
- [Diagnosis and problems in therapy of interstitial lung disease associated with rheumatoid arthritis].
- Authors: Bestaev DV, Karateev DE, Nasonov EL
- Issue date: 2013
- Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern.
- Authors: Kim EJ, Collard HR, King TE Jr
- Issue date: 2009 Nov